0000899243-22-001807.txt : 20220112
0000899243-22-001807.hdr.sgml : 20220112
20220112193012
ACCESSION NUMBER: 0000899243-22-001807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220110
FILED AS OF DATE: 20220112
DATE AS OF CHANGE: 20220112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mainolfi Nello
CENTRAL INDEX KEY: 0001821189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 22527560
MAIL ADDRESS:
STREET 1: C/O KYMERA THERAPEUTICS, INC.
STREET 2: 200 ARSENAL YARDS, SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-10
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001821189
Mainolfi Nello
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
1
1
0
0
Chief Executive Officer
Common Stock
2022-01-10
4
M
0
22465
2.08
A
494664
D
Common Stock
2022-01-10
4
S
0
7485
52.4574
D
487179
D
Common Stock
2022-01-10
4
S
0
10673
53.3476
D
476506
D
Common Stock
2022-01-10
4
S
0
4201
54.4026
D
472305
D
Common Stock
2022-01-10
4
S
0
106
54.99
D
472199
D
Common Stock
2022-01-11
4
M
0
16923
2.08
A
489122
D
Common Stock
2022-01-11
4
S
0
9932
53.6759
D
479190
D
Common Stock
2022-01-11
4
S
0
6644
54.4224
D
472546
D
Common Stock
2022-01-11
4
S
0
347
55.0529
D
472199
D
Common Stock
2022-01-12
4
M
0
8612
2.08
A
480811
D
Common Stock
2022-01-12
4
S
0
2726
51.3122
D
478085
D
Common Stock
2022-01-12
4
S
0
4022
52.0163
D
474063
D
Common Stock
2022-01-12
4
S
0
1623
53.27
D
472440
D
Common Stock
2022-01-12
4
S
0
241
53.97
D
472199
D
Stock Option (Right to Buy)
2.08
2022-01-10
4
M
0
22465
0.00
D
2029-11-13
Common Stock
22465
599815
D
Stock Option (Right to Buy)
2.08
2022-01-11
4
M
0
16923
0.00
D
2029-11-13
Common Stock
16923
582892
D
Stock Option (Right to Buy)
2.08
2022-01-12
4
M
0
8612
0.00
D
2029-11-13
Common Stock
8612
574280
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.99 to $52.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.99 to $53.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.99 to $54.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $54.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.01 to $54.995. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.05 to $55.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.60 to $51.575. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.88 to $53.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.
/s/ Bruce Jacobs, as Attorney-in-Fact
2022-01-12